ESNT vs GSK · P/E 8.2, rev $698.8M vs P/E 13, $103.31B cap
Essent Group Ltd (ESNT) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Essent Group Ltd (ESNT) is a insurance - specialty company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ESNT revenue for 2026-06-30 was $698.8M. Net income was $361.5M. ESNT currently screens at market cap $5.33B and trailing P/E 8.2.
GSK does not have a complete income-statement cache yet.
ESNT currently screens at market cap $5.33B and trailing P/E 8.2. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ESNT and GSK stock pages for the full models.
Not investment advice.